Development of a prognostic model to identify the metastatic nasopharyngeal carcinoma patients who may benefit from chemotherapy combination PD-1 inhibitor

Development of a prognostic model to identify the metastatic nasopharyngeal carcinoma patients who may benefit from chemotherapy combination PD-1 inhibitor

BackgroundWe aimed to establish a prognostic model to identify suitable candidates for chemotherapy combination PD-1 inhibitor in metastatic nasopharyngeal carcinoma (NPC) patients.Patients and methodsIn this retrospective study, we included 524 patients (192 patients treated with chemotherapy combi...

Full description

Bibliographic Details
Main Authors: Guo-Ying Liu, Nian Lu, Wei-Xin Bei, Wang-Zhong Li, Hu Liang, Wei-Xiong Xia, Yan-Qun Xiang, He-Rui Yao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
nasopharyngeal carcinoma
PD-1 inhibitor
prognostic model
propensity matching analysis
progression-free survival
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1069010/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1069010/full

Similar Items